Masakazu Yashiro Selected Research

Masakazu Yashiro Research Topics

Disease

147	Neoplasms (Cancer) 06/2024 - 01/2002
115	Stomach Neoplasms (Stomach Cancer) 06/2024 - 11/2002
43	Carcinoma (Carcinomatosis) 01/2022 - 11/2002
41	Neoplasm Metastasis (Metastasis) 10/2023 - 05/2002
14	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 05/2002
14	Lymphatic Metastasis 01/2023 - 11/2002
13	Esophageal Neoplasms (Esophageal Cancer) 09/2021 - 09/2005
12	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 07/2003
9	Hypoxia (Hypoxemia) 09/2023 - 01/2010
9	Microsatellite Instability 01/2023 - 01/2004
7	Adenocarcinoma 05/2020 - 12/2003
6	Carcinogenesis 12/2023 - 03/2006
6	Inflammation (Inflammations) 01/2022 - 08/2015
6	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2007
6	Fibrosis (Cirrhosis) 11/2015 - 02/2007
5	Esophageal Squamous Cell Carcinoma 09/2021 - 09/2005
4	Ascites 11/2016 - 11/2006
4	Adenoma (Adenomas) 12/2011 - 11/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 10/2021
3	Rectal Neoplasms (Rectal Cancer) 09/2023 - 11/2017
3	Anastomotic Leak 09/2021 - 05/2014
3	Infections 09/2014 - 08/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2013 - 11/2009
3	Disease Progression 04/2011 - 11/2004
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
15	Fluorouracil (Carac)FDA LinkGeneric 06/2014 - 09/2005
14	Messenger RNA (mRNA)IBA 06/2024 - 12/2003
14	Biomarkers (Surrogate Marker)IBA 05/2023 - 11/2010
10	Paclitaxel (Taxol)FDA LinkGeneric 05/2019 - 09/2006
10	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 02/2007
9	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023 - 02/2007
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 12/2005
8	Indicators and Reagents (Reagents)IBA 01/2022 - 05/2002
8	Phosphotransferases (Kinase)IBA 11/2020 - 05/2008
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2002
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2004
7	C-Reactive ProteinIBA 01/2022 - 11/2013
7	AntibodiesIBA 05/2021 - 04/2009
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2020 - 09/2006
7	Vascular Endothelial Growth Factor CIBA 08/2016 - 01/2003
6	ParaffinIBA 01/2024 - 11/2002
6	RNA (Ribonucleic Acid)IBA 01/2024 - 12/2003
6	Cadherins (E-Cadherin)IBA 01/2024 - 01/2011
6	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2014
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 09/2006
6	Small Interfering RNA (siRNA)IBA 04/2016 - 04/2012
6	Monoclonal AntibodiesIBA 04/2013 - 05/2002
5	VimentinIBA 01/2024 - 10/2004
5	Conditioned Culture MediaIBA 07/2022 - 04/2005
5	CytokinesIBA 07/2022 - 09/2003
5	IntegrinsIBA 01/2022 - 05/2008
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2021 - 12/2003
5	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 10/2011
4	CXC ChemokinesIBA 01/2022 - 12/2015
4	AlbuminsIBA 09/2021 - 06/2018
4	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021 - 04/2008
4	Keratins (Keratin)IBA 01/2020 - 10/2004
4	human ERBB2 proteinIBA 01/2015 - 01/2011
4	nedaplatinIBA 11/2013 - 11/2009
4	Gemcitabine FDA Link 05/2013 - 09/2006
4	Ki23057IBA 08/2011 - 11/2006
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2007 - 07/2005
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2005 - 05/2002
3	Formaldehyde (Formol)FDA Link 01/2024 - 11/2002
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2023
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 02/2016
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 02/2004
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 05/2021 - 04/2013
3	Decitabine FDA Link 01/2020 - 01/2009
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 12/2014
3	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2018 - 11/2014
3	MTOR InhibitorsIBA 12/2015 - 12/2009
3	Bevacizumab (Avastin)FDA Link 08/2012 - 11/2008
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2012 - 06/2010
3	Histones (Histone)IBA 11/2010 - 09/2006
3	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 08/2010 - 05/2008
3	Fibroblast Growth Factor 7 FDA Link 04/2009 - 12/2003
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2007 - 12/2006
3	ThymidineIBA 02/2007 - 12/2003
2	A-factor (Streptomyces)IBA 10/2023 - 11/2004
2	Calcibiotic Root Canal SealerIBA 09/2023 - 06/2010
2	Pyruvic Acid (Pyruvate)IBA 01/2023 - 10/2021
2	Galectin 3 (LGALS3)IBA 01/2023 - 10/2015
2	InterferonsIBA 11/2021 - 09/2005

Therapy/Procedure

41	Therapeutics 12/2023 - 11/2002
18	Gastrectomy 01/2023 - 03/2006
18	Drug Therapy (Chemotherapy) 12/2021 - 02/2004
10	Esophagectomy 09/2021 - 04/2013
6	Radiotherapy 01/2020 - 01/2009
5	Chemoradiotherapy 11/2013 - 11/2009
4	Precision Medicine 01/2024 - 02/2018
4	Neoadjuvant Therapy 02/2020 - 10/2009
4	Combination Drug Therapy (Combination Chemotherapy) 11/2013 - 11/2009
3	Immunotherapy 01/2023 - 11/2021
3	Laparotomy 02/2019 - 05/2014
3	Adjuvant Chemotherapy 12/2013 - 11/2009